Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 12, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$8.43B
sum of reported positions
Reported positions
590
Changes vs prior quarter
597
102 new · 88 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 459 measured positions in 8 quarters, the typical new or larger position finished −1.5 pts against the S&P 500 and 45% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
| Company | Shares | Value | Weight |
|---|---|---|---|
| 693K | $139M | 1.6% | |
| 1.03M | $126M | 1.5% | |
| 423K | $122M | 1.5% | |
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.
Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $6.98B | $8.43B |
| Positions | 576 | 590 |
| Biggest line | — | NVIDIA 2% |
| 828K |
| $120M |
| 1.4% |
| 206K | $119M | 1.4% |
| 268K | $100M | 1.2% |
| 398K | $95M | 1.1% |
| 314K | $93.4M | 1.1% |
| 204K | $92.9M | 1.1% |
| 216K | $82.2M | 1.0% |
| 1.05M | $78.7M | 0.9% |
| 182K | $77.2M | 0.9% |
| 1.45M | $69.3M | 0.8% |
| 192K | $68M | 0.8% |
| 531K | $63.6M | 0.8% |
| 99K | $63.6M | 0.8% |
| 701K | $63.3M | 0.8% |
| 161K | $60.7M | 0.7% |
| 394K | $60.3M | 0.7% |
| 1.16M | $59.9M | 0.7% |
| 499K | $58.5M | 0.7% |
| 584K | $58.3M | 0.7% |
| 360K | $57.7M | 0.7% |
| 796K | $57.6M | 0.7% |
| 3.09M | $57.5M | 0.7% |
Viking Holdings (VIK)
49K shares
Dover Corporation (DOV)
24K → 23K shares (−5%)
Haemonetics (HAE)
74K → 68K shares (−8%)
Firefly Aerospace (FLY)
169K shares
Coeur Mining (CDE)
336K → 304K shares (−10%)
Ssr Mining (SSRM)
207K → 169K shares (−18%)
Hub Group, Inc. (HUBG)
285K → 109K shares (−62%)
Procept Biorobotics (PRCT)
208K → 211K shares (+2%)
Sarepta Therapeutics (SRPT)
258K shares
Valley Bank (VLY)
343K → 316K shares (−8%)
Kiniksa Pharmaceuticals International (KNSA)
72K shares
Cigna (CI)
17K shares
Qualys (QLYS)
35K → 33K shares (−6%)
Aurinia Pharmaceuticals (AUPH)
146K → 264K shares (+80%)
Kennametal (KMT)
141K → 127K shares (−10%)
Hamilton Insurance Group (HG)
146K → 131K shares (−10%)
Dauch Corporation (DCH)
147K → 800K shares (+444%)
Avery Dennison (AVY)
28K → 26K shares (−5%)
Stanley Black & Decker (SWK)
15K → 46K shares (+200%)
Manhattan Associates (MANH)
48K → 31K shares (−35%)
Douglas Dynamics (PLOW)
84K → 78K shares (−8%)
Resideo Technologies, Inc. (REZI)
154K → 135K shares (−13%)
Columbus Mckinnon (CMCO)
720K → 276K shares (−62%)
Amneal Pharmaceuticals (AMRX)
278K → 240K shares (−14%)
Tutor Perini Corporation (TPC)
50K shares
